Web Based Technology

12 Months Ended

Dec. 31, 2014

NOTE 5 – WEB-BASED TECHNOLOGY

The Company has capitalized costs in developing their web-based technology, which consisted of the following as of December 31, 2014 and 2013:

	2014			2013
OptimizeRx web-based technology	$	154,133		$	154,133
SampleMD web-based technology		602,517			602,517
SampleMD 2.0 web-based technology		440,477			148,060
Subtotal, web-based technology		1,197,127			904,710
Accumulated amortization		(633,401	)		(440,641	)
Impairment		(59,083	)		(59,083	)
Web-based technology, net	$	504,643		$	404,986

Amortization is recorded using the straight-line method over a period of up to five years. During 2014, the Company launched its SampleMD 2.0 web-based technology. The OptimizeRx web-based technology was fully impaired in 2010 and has no remaining carrying value. Amortization expense for the web-based technology costs was $192,760 and $130,289 for the years ended December 31, 2014 and 2013, respectively.